Scientists discover brain switches that clear Alzheimer’s plaques
Karolinska-linked study finds somatostatin receptor subtypes 1 and 4 upregulate neprilysin, lowering amyloid-beta and improving memory in mice, suggesting common drug targets could enable affordable oral Alzheimer's treatments.
Why it mattersPrioritize screening somatostatin receptor 1 and 4 agonists to advance oral Alzheimer's drug candidates.